rs148166997
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PP3_ModerateBS2
The NM_000435.3(NOTCH3):c.154G>A(p.Gly52Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000993 in 1,611,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000435.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151854Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 245858Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134192
GnomAD4 exome AF: 0.00000959 AC: 14AN: 1459924Hom.: 0 Cov.: 35 AF XY: 0.00000826 AC XY: 6AN XY: 726220
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151854Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74170
ClinVar
Submissions by phenotype
not provided Uncertain:3
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 52 of the NOTCH3 protein (p.Gly52Arg). This variant is present in population databases (rs148166997, gnomAD 0.003%). This missense change has been observed in individual(s) with clinical features of NOTCH3-related conditions (PMID: 31836585). ClinVar contains an entry for this variant (Variation ID: 447788). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NOTCH3 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity. (http://gnomad.broadinstitute.org) In our internal patient population, this variant is statistically more frequent than in the general population, which is weak evidence this variant may be disease causing. This variant has been identified in at least one individual with clinical features associated with CADASIL. This variant has been identified in cis with NOTCH3 c.133G>C in published literature, general population data, and our internal patient data (PMID: 31836585, The Genome Aggregation Database (gnomAD), Athena Diagnostics internal data). Polyphen and MutationTaster predict this amino acid change may be damaging to the protein. Greater than 90% of NOTCH3 pathogenic variants associated with CADASIL involve the gain or loss of a cysteine residue within the epidermal growth factor (EGF)-like repeat domain (PMID: 32457593, 20301673). -
BP1, PP3 -
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Uncertain:1Other:1
- -
Variant interpreted as Uncertain significance and reported on 10-23-2020 by lab or GTR ID London Health Sciences Centre/St. Joseph's Health Care London, Pathology and Laboratory Medicine. GenomeConnect - CureCADASIL assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
not specified Uncertain:1
The NOTCH3 c.154G>A; p.Gly52Arg variant (rs148166997) is reported in the literature in cis to a p.Asp45His missense variant in individual affected with cerebral small vessel disease with a family history of stroke and migraines (Tan 2018). The p.Gly52Arg variant is reported in ClinVar (Variation ID: 447788), and it is found on only three chromosomes (3/245858 alleles) in the Genome Aggregation Database. The glycine at codon 52 is highly conserved and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. However, due to limited information, the clinical significance of the p.Gly52Arg variant is uncertain at this time. References: Tan, YYR. Genetics of Cerebral Small Vessel Disease (Doctoral thesis). 2018. https://doi.org/10.17863/CAM.30570 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at